BLMN Bloomin' Brands, Inc. Insider Trading

Director Lal Rohit buys 10,000 shares of BLMN at $5.69; stock now $5.44, -48.4% from 52-week high.

Lal Rohit purchased 10,000 shares at $5.69 on 2026-03-11, increasing his holdings by 49.6% to 30.2K shares. The purchase occurred as the stock trades $5.44, down 21.8% in the 30 days since the transaction and 48.4% below its 52-week high of $10.54. His prior buy at this ticker (2025-02-28) showed -23.0% over 30 days and -19.8% over 90 days, and his cross-ticker track record shows 0 of 1 prior buys were well-timed at the 90-day mark, with an average 90-day return of -19.8%. Underlying fundamentals show the company reported net income of -$45.9M in the latest quarter against revenue of $928.8M, with annual growth flat at +0.1% and a low P/E of 5.91.

Director Julie T. Kunkel buys 1,000 BLMN shares at $6.46 amid -44.9% year-to-date decline; stock down -17.8% in 30 days.

Director Julie T. Kunkel purchased 1,000 shares at $6.46 on 2026-03-05, increasing her holdings by 19.7% to 6,065 shares. The stock is trading at $5.81, down from a 52-week high of $10.54 (a -44.9% decline) and has fallen -17.8% over the prior 30 days. Kunkel's prior three trades at BLMN show mixed timing outcomes: one buy appreciated 13.5% by the 90-day mark, but a second buy subsequently declined -22.4%, suggesting discretionary judgment has been inconsistent at this ticker. Fundamental context is concerning: the company generated $928.8M in quarterly revenue but reported a net loss of $-45.9M, with minimal annual revenue growth of +0.1%, though the low P/E of 6.32 may reflect distressed pricing rather than opportunity.

Director Kunkel buys 1,500 shares at $6.37 amid -61.3% decline from 52-week high; unprofitable company and poor insider track record.

Kunkel Julie T. purchased 1,500 shares at $6.37 on 2025-11-11, increasing her holdings by 42.1% from 3,565 to 5,065 shares. The transaction occurs as the stock trades at $6.49, substantially below the 52-week high of $16.78 (-61.3%), and follows a 10.6% decline over both the 30-day and 90-day periods. Notably, the company reported negative net income of $-45.9M on quarterly revenue of $928.8M and contracted 15.4% year-over-year, indicating fundamental operational stress. Kunkel's prior purchase at this ticker on 2025-02-28 fell 25.4% over 30 days and 22.4% over 90 days, establishing a pattern of poorly timed entry points; across her broader trading history, 0 of 2 prior buys achieved positive 90-day returns. This purchase offers no clear conviction signal—it appears driven by depressed valuation in a deteriorating business rather than by management confidence in recovery.

CFO Eric C. bought 150,000 shares of BLMN at $6.38 for $957.0K; stock down -61.3% YTD from $16.78 high, company unprofitable.

Christel Eric C., the company's CFO, made an open-market purchase of 150,000 shares at $6.38 on 2025-11-10, establishing a first position in the company stock. The timing of this buy coincides with significant stock weakness: the current price of $6.49 represents a -61.3% decline from the 52-week high of $16.78, and the stock is down -10.6% over both the 30-day and 90-day periods. Separately, the company's fundamentals are pressured: it reported a net loss of $45.9M in the latest quarter and full-year revenue declined -15.4% year-over-year, with the company unprofitable on an annual basis. An insider executive purchase of this magnitude at these depressed levels occurs against a backdrop of both operational underperformance and extended stock weakness.

CEO Spanos buys 118,000 BLMN shares at $8.63; stock down -71.2% from 52-week high, cluster buy with 2 other insiders in 14 days

CEO Mike Spanos purchased 118,000 shares of Bloomin' Brands for $1,018,340.00 at $8.63, establishing an initial position in the company. The timing coincides with severe downward pressure: the stock trades at $8.56, down -71.2% from its 52-week high of $29.72 and -32.2% over the past 30 days. Spanos's cross-ticker insider track record shows 3 prior buys with an average 90-day return of +12.7% and a 100% win rate, suggesting his historical purchases have been positioned favorably. Compounding the signal, 2 other insiders also bought within the past 14 days, forming a cluster buy pattern. However, Bloomin' Brands faces material headwinds: full-year net income is negative, revenue contracted -15.4% year-over-year, and the latest quarter's net income of $6.9M is minimal relative to revenue of $1.0B, indicating operational stress.

Director Kunkel buys 1,500 shares of BLMN at $9.94; stock now $8.24, down -72.3% from 52-week high.

Julie T. Kunkel, a Director, purchased 1,500 shares at $9.94 on 2025-02-28, increasing her holdings by 72.6% from 2,065 to 3,565 shares. The transaction occurred as BLMN trades 72.3% below its 52-week high of $29.72 and has declined 34.4% over 30 days and 36.2% over 90 days, signaling sustained weakness. Kunkel's cross-ticker buy track record shows 1 prior purchase averaging 2.8% return in 30 days but -3.2% over 90 days with a 0% win rate, and her single prior trade at BLMN (August 2024 buy) exhibited the same -3.2% 90-day outcome with 0 of 1 prior buys well-timed. Fundamental conditions remain stressed: the company faces -15.4% annual revenue contraction and was unprofitable over its most recent full fiscal year, with latest quarter net income at $6.9M against $1.0B revenue.

Director Lal Rohit bought 10,000 shares of BLMN at $9.62 (Feb 28); stock down -34.4% in 30 days, -72.3% from 52-week high.

Director Lal Rohit purchased 10,000 shares at $9.62 on 2025-02-28, increasing his holdings from 4,018 to 14,018 shares, a +248.9% increase. The purchase occurred in a deteriorating market environment: the stock has fallen -34.4% over the prior 30 days and -72.3% from its 52-week high of $29.72, trading at $8.24 today. Bloomin' Brands is facing significant headwinds, with annual revenue declining -15.4% year-over-year and the company posting negative net income over its most recent full fiscal year despite $1.0B in quarterly revenue. Rohit's cross-ticker insider track record shows 7 prior open-market sells with a 100.00% well-timed rate and -22.5% average 90-day return, indicating his sells have historically preceded downward moves. This buy occurs at a notably deteriorated valuation but amid ongoing operational challenges at the company.

Director Kunkel Julie T. purchases 1,000 BLMN shares at $15.65, doubling holdings to 2,000 shares as stock down -45.2% from 52-week high.

Director Kunkel Julie T. acquired 1,000 shares of Bloomin' Brands at $15.65 on 2024-08-12, bringing total holdings from 1,000 to 2,000 shares (a +100.0% increase in position size). The acquisition occurred at a price substantially below the 52-week high of $29.72, with the stock trading -45.2% from that peak and -9.0% over the prior 30 days. The company maintains a low P/E of 5.74 with positive fundamentals including $1.1B quarterly revenue and $28.4M net income. This purchase by a director during a period of significant stock weakness, combined with doubled personal ownership, may indicate insider conviction at current valuations, though the recent 90-day decline of -32.2% and modest transaction size warrant observation of broader insider activity patterns to establish confidence in directional intent.